CBER Director Marks: Regenerative Medicine Enforcement Will Be 'Notched Up' In 2018

In an interview with the Pink Sheet, Marks said the guidances on regenerative medicines make clear what the agency will be enforcing.

More from Cell & Gene Therapies

More from Advanced Technologies